from previous structural and mutagenic studies. Mutagenesis also revealed that the native structure of profilin is very sensitive to substitutions and deletions at the C terminus. For example, profilin with a deletion of the eight C-terminal residues has many of the physical properties of a molten globule, yet remarkably still binds to actin. This instability may account for the lack of function of similar mutants in yeast.
Introduction
Profilin has attracted considerable attention as a regulator of actin assembly, a possible participant in phosphoinositide signaling and a human allergen (Valenta et al., 1992) . It is a small soluble protein that binds to multiple ligands including actin (Carlsson et al., 1977) , polyphosphoinositides (Lassing & Lindberg, 1985) , poly-L-proline (Tanaka & Shibata, 1985) and a complex of seven proteins including two actin-related proteins (ARPs; Machesky et al., 1994a,b) . Profilin is essential for the normal function of yeast (Balasubramanian et al., 1994; Haarer et al., 1990; Magdolen et al., 1988) , slime molds (Haugwitz et al., 1994) and flies (Verheyen & Cooley, 1994 ), but we do not yet know which of its multiple interactions are essential for normal cellular physiology. Some (Acanthamoeba castellanii, Dictyostelium discoidium, Physarum polycephalum, echinoderms, humans and plants) but not all (Saccharomyces cerevisiae and Schizosaccharomyces pombe) organisms express more than one isoform of profilin (Machesky & Pollard, 1993) . Drosophila melanogaster regulates profilin expression from a single gene using two transcriptional promoters (Cooley et al., 1992) .
We now know the atomic structures of five profilins: Acanthamoeba profilin-I (Fedorov et al., 1994; Vinson et al., 1993) , Acanthamoeba profilin-II (Fedorov et al., 1994) , bovine profilin (CedergrenZeppezauer et al., 1994; Schutt et al., 1993) , human profilin and birch pollen profilin (Almo, S. E., personal communication) . Given the highly divergent primary structures of profilins (reviewed by Pollard & Quirk, 1994) , the atomic structures are remarkably similar. These structures, chemical crosslinking, solution NMR, mutagenesis and phylogenetic comparisons have provided some strong initial clues about the binding sites for actin (Haarer et al., 1993; Schutt et al., 1993; Vandekerckhove et al., 1989) , poly-L-proline (Archer et al., 1994; Metzler et al., 1994; Bjorkegren et al., 1993; Haarer et al., 1993) and polyphosphoinositides (Sohn et al., 1995; Cedergren-Zeppezauer et al., 1994; Fedorov et al., 1994; Haarer et al., 1993) .
To obtain independent evidence about the relation of profilin structure to function, we characterized the biochemical properties of several profilin mutants and nine monoclonal antibodies to Acanthamoeba profilin. We used the deletion and substitution mutants to map the antibody binding sites, but these mutations also provided some additional information about ligand binding. The Abbreviations used: ARP, actin-related protein; ANS, 1-anilino-naphthalene-8-sulfonic acid; PCR, polymerase chain reaction; IPTG, isopropyl-b-D-thiogalactopyranoside; HAT, hypoxanthine/ aminopterin/thymidine; DMEM, Dulbecco's modified Eagle's medium; EGTA, ethyleneglycol bis (b-aminoethylether)-N,N'-tetraacetic acid; CPM, counts per minute; CD, circular dichroism; FBS, fetal bovine serum. results confirm the location of the binding sites for actin and poly-L-proline inferred from other studies and provide new insights about the stability of the protein.
Results

Characterization of recombinant profilin
Recombinant Acanthamoeba profilin-I and profilin-II purified from Escherichia coli are very similar to the native profilins by several criteria. The recombinant profilins are easily purified from bacterial cell lysates using DEAE and poly-L-proline affinity chromatography . Recombinant and native profilins have the same effects on actin nucleotide exchange and bind to actin with the same affinity . Recombinant and native profilins show the same changes in tryptophan fluorescence associated with poly-L-proline binding (Machesky, 1993;  Table 1 ) and urea denaturation  Table 1 ). One difference is that recombinant profilin-I and profilin-II have higher isoelectric points than their native counterparts as determined by isoelectric focusing (Table 1) .
Physical properties of recombinant profilin mutants
We constructed 20 different C-terminal deletion mutants of profilin-II and two point mutants of profilin-I and expressed them in E. coli. None of the deletion mutants bound to the poly-L-proline affinity column, so we used conventional chromatography to purify them, in either urea or physiological buffers (Figure 1 ). The point mutants and some mutants with deletions of E8 residues were soluble (1 to 3 mg/ml) in physiological buffers. Several mutants with deletions e8 residues could be purified in urea, but were not suitable for biochemical studies because of their insolubility in physiological buffers.
We concentrated on the characterization of wild-type profilin-II and three deletion mutants that can be purified in biochemical quantities and are soluble in physiological buffers. Figure 2 provides orientation for the site of the deletions. The C-terminal F125 is blue. The green K115 provides a convenient marker for the middle of the C-terminal helix a4. Wild-type profilin-II is rPII 122QGF and the mutants are rPII 122PLV (profilin-II with Pro-Leu-Val substituted for Q123-G124-F125 at the C terminus), rPII 122PSSLD (profilin-II with Pro-Ser-Ser-Leu-Asp substituted for Q123-G124-F125 at the C terminus) and rPII 117PLV (profilin-II with Pro-Leu-Val substituted for D118-Y119-L120-I121-G122-Q123-G124-F125 at the C terminus). Several experiments were conducted with rPII (Federov et al., 1994) . Top: stereo pair of a ribbon model showing the N terminus, aromatic residues W2, W29 and F125 (P4/P6 determinants) in blue; residues 22 to 44 (P8/P9 epitope) in yellow; residues 75 to 89 (segment homologous to actin and myosin-II) including the S76 side-chain (P7 determinant) in red, S92 (P5 determinant) in lavender; residues 101 to 104 (P3 epitope) in orange; and K115 (residue crosslinked to E364 of actin; Vandekerckhove et al., 1989) in green. Bottom: stereo pair of a space-filling model showing residues homologous to the actin contact residues in the bovine profilin-beta-actin complex in blue and green, S76 in red, S92 in lavender, residues 101 to 104 in orange and K115 in green. The Figure was produced with the SETOR program (Evans, 1993) on a Silicon Graphics IRIS computer.
118PLV. The deletion mutants rPII 117L and rPII 115PLV are not soluble in physiological buffers. Some of the physical and functional properties of the purified mutants are summarized in Table 1 .
At 5°C, wild-type rPII 122QGF, rPII 122PLV, rPII 122PSSLD and the deletion mutant rPII 117PLV have similar intrinsic fluorescence with the emission maximum at 333 nm ( Figure 3A ). The two tryptophan residues (W2 and W29) are shown in blue in Figure 2 . At 37°C, rPII 122PLV, rPII 122PSSLD and rPII 117PLV have a higher intrinsic fluorescence than wild-type rPII 122QGF, particularly at 350 nm ( Figure 3B ). Urea causes an increase of intrinsic fluorescence at 350 nm for both wild-type and mutant profilins, but the transition occurs at lower urea concentrations for the mutants ( Figure 3C ). We calculated the apparent equilibrium constants (K app ) for the transitions and determined the free energy of unfolding (DG°F -U ) for each mutant by extrapolating plots of − RT ln K app versus urea concentration to zero urea ( Figure 3C , inset). Wild-type profilin has a DG°of 7.6 kcal/mol compared to 3.2 kcal/mol for rPII 122PLV, 3.0 kcal/ mol for rPII 122PSSLD and 1.8 kcal/mol for rPII 117PLV.
Wild-type profilin (rPII 122QGF) does not bind 1-anilinonaphthalene-8-sulfonic acid (ANS) between 5 and 45°C, but the mutants do bind ANS within this range ( Figure 4A and B). Mutants rPII 122PSSLD and rPII 122PLV bind ANS only at temperatures above 20°C ( Figure 4A and B). The deletion mutant, rPII 117PLV, binds ANS even at 5°C (data not shown). Both the rate and the extent of the fluorescence changes are dependent on temperature for each of the mutants. Eyring (Arrhenius) plots ( Figure 4C ) of the initial rates of ANS binding are linear and yield activation enthalpies (DH ‡) of 34 kcal/mol for rPII 117PLV, 53 kcal/mol for rPII 122PSSLD and 59 kcal/mol for rPII 122PLV. A plot of DH ‡ versus DG°for each mutant yields a straight line passing through the origin ( Figure 4C, inset) . We can extrapolate this curve to a predicted DH ‡ of about 140 kcal/mol for wild-type profilin (rPII 122QGF).
The CD spectra and Stokes' radii of the C-terminal mutants are similar to wild-type profilin ( Table 1 ). The CD spectra of rPII 122QGF, rPII 122PLV and rPII 122PSSLD are indistinguishable in the range of 187 to 245 nm (data not shown). Minor differences in the CD spectrum of rPII 117PLV could be accounted for by the missing a-helical residues (data not shown). The substitution mutant rPII 122PLV and the deletion mutant rPII 117PLV elute just ahead of wild-type rPII 122QGF on gel filtration, indicating slightly larger Stokes' radii (Table 1) .
Functional properties of recombinant profilin mutants
Wild-type rPII 122QGF binds quantitatively to poly-L-proline in the pelleting assay, but the substitution mutant rPII 122PLV binds less well (Figure 5, inset) . We quantified the binding of profilin to poly-L-proline by fluorescence enhancement. Wild-type rPII 122QGF has a dissociation Wild-type and mutant profilins at a concentration of 4.0 mM in 10 mM Tris-HCl buffer (pH 7.8) were titrated with 10 mg/ml poly-L-proline (Mr 30,000) at 20°C. Shown is the normalized fluorescence at 325 nm for each sample as a function of proline residues added. Excitation was at 295 nm. Filled circles, wildtype rPII 122QGF; open circles, rPII 122PLV; filled triangles, rPII 122PSSLD; open triangles, rPII 117PLV. The curves are the best hyperbolic fits determined by least squares regression for the data points. Inset: binding of profilins to poly-L-proline Sepharose beads in a pelleting assay. Samples of 280 mg of wild-type rPII 122QGF and mutant rPII 122PLV profilins were incubated with 50 ml of packed poly-Lproline beads (10 mg/ml of Mr 30,000 poly-L-proline) in 1.5 ml bead buffer on a rotary shaker for 60 minutes at 4°C. The beads were pelleted and rinsed four times with 1.0 ml of bead buffer. Samples were run on 15% Laemmli SDS-PAGE and stained with Coomassie blue. Lanes 1, 2 and 3, wild-type rPII 122QGF sample, supernatant and pellet, respectively. Lanes 4, 5 and 6, rPII 122PLV sample, supernatant and pellet, respectively. equilibrium constant of 0100 mM proline residues. Mutants rPII 122PLV and rPII 122PSSLD have dissociation equilibrium constants that are at least 100 times higher ( Figure 5 , Table 1 ), as expected from the known participation of F125 (shown in blue in Figure 2 ) in the binding site (Archer et al., 1994) . The deletion mutant rPII 117PLV shows no detectable binding to poly-L-proline by fluorescence enhancement ( Figure 5 ) or by pelleting (data not shown). Also, the deletion mutant rPII 118PLV does not bind to poly-L-proline in the pelleting assay (data not shown).
Although the mutants with modified C termini do not bind well to poly-L-proline, all three of these mutants, including rPII 117PLV, which is missing the last two turns of the C-terminal helix (see Figure 2 ), are equally potent in inhibiting the spontaneous, salt-induced polymerization of actin monomers ( Figure 6 ).
Characterization of monoclonal antibodies to ameba profilin
We characterized nine monoclonal antibodies made against wild-type profilin-I and profilin-II purified from A. castellanii by conventional methods (Table 2 ). Hybridoma cells were selected and cloned based on the binding of their antibody products to profilin in solid phase ELISA. In solution binding experiments, only antibodies P4, P5, P6 and P7 bind Figure 6 . Effects of profilin mutants on the initial rate of actin polymerization. Rabbit skeletal muscle actin at a concentration of 10.0 mM in buffer A was polymerized in the presence of wild-type or mutant profilins and the time course of polymerization was monitored by light scattering. Open squares, actin without profilin added; filled circles, 12 mM wild-type rPII 122QGF; open circles, 13 mM rPII 122PLV; filled triangles, 11 mM rPII 122PSSLD; open triangles, 14 mM rPII 117PLV. to profilin-I and profilin-II. Antibodies P1, P2, P3, P8 and P9 do not bind profilin-I or profilin-II in solution. By ELISA and immunoblotting, however, all of the antibodies (P1 to P9) bind to profilin-II, but only P1 to P7 bind to profilin-I. Antibodies P8 and P9 are specific for profilin-II. The small differences in the apparent affinities of some of the antibodies for wild-type profilins purified from Acanthamoeba and E. coli may be related to differences in charge (Table 1 ) and/or processing of these profilins. Profilin produced by amebae has an acetylated N terminus and a trimethylated lysine at position 103 (Ampe et al., 1988 (Ampe et al., , 1985 . Since all nine of the monoclonal antibodies bind to profilin-II, we chose this isoform for deletion mutagenesis to determine the antibody epitopes.
Epitope localization
We used the profilin-II deletion mutants in solid phase binding assays (ELISA and immunoblotting) to determine the epitopes for antibodies P1, P2, P3, P8 and P9 ( Figure 7 ). The antibodies that bind native profilin (P4, P5, P6 and P7) do not bind any deletion mutant in either solution or solid phase binding assays, except for the weak reactivity to the internal deletion rPIID61-65A seen in Figure 7E and the binding of P7 to rPII 122PLV and rPII 122PSSLD ( Figure 8C ). We therefore used the profilin-I point mutations rPIS76C and rPIS92C ( Figure 8B and C) and the profilin-II point mutations rPIIW2C and rPIIW29C (data not shown) to identify the epitopes for these antibodies, employing both solution and solid phase (data not shown) binding assays. Competitive binding assays provided additional information about the proximities of the localized epitopes ( Figure 9 ).
Antibodies that bind to denatured epitopes
In solid phase binding assays, antibody P3 binds all of the C-terminal deletions from wild-type down to rPII 104PSSLD and rPII 104PLV, but it does not bind rPII 100TSSLD ( Figure 7C ) or rPII 94L (data not shown). Therefore, the epitope for antibody P3 includes residues between 101 and 104 (NEKI) of profilin-II (shown in orange in Figure 2 ). Antibody P3 also binds to each of the internal deletions rPIID5-62, rPIID16-46, rPIID47-65 and rPIID61-65A ( Figure 7C ) and to wild-type profilin-I, as well as rPIS76C, rPIS92C, rPIIW2C and rPIIW29C (data not shown). Each of these proteins contains the NEKI sequence. These residues form a loop that connects strand b8 with the C-terminal helix a4 in the native structure (see Figure 2 ). In solution, antibody P3 does not bind to wild-type rPII 122QGF or to the substitution mutant rPII 122PLV, but remarkably, it does bind to the deletion mutant rPII 117PLV ( Figure 8A ).
In solid phase assays, antibody P2 binds to wild-type rPII 122QGF and each of the four internal deletions, rPIID5-62, rPIID16-46, rPIID47-65 and rPIID61-65A, which contain wild-type primary Figure 7 . Binding of monoclonal antibodies to profilin-II mutants by immunoblotting. BL21(DE3) E. coli cells containing MW172 expression plasmids for each mutant were induced with 0.5 mM IPTG and grown overnight in 3.0 ml TB at 37°C. Cells were harvested and boiled in 1.0 ml of SDS sample buffer and 10 ml of each cell sample was applied to a 15% Laemmli SDS-PAGE gel containing 6 M urea. The names of the mutants are shown at the top of each lane. A, Gel of mutants stained with Coomassie blue. B to E, immunoblots. Gels identical to that in A were transfered to nitrocellulose and incubated with monoclonal antibodies followed by HRP-GAM antibodies as described in Materials and Methods. B, Antibody P8 (same for P9); C, antibody P3; D, antibody P2 (same for P1); E, antibody P4 (same for P5, P6 and P7).
structure at the C terminus, but it does not bind any C-terminal deletions, substitutions or extensions ( Figure 7D ). Antibody P2 also binds to profilin-I (Table 1 ) and the point mutants rPIS76C, rPIS92C, rPIIW2C and rPIIW29C (data not shown). Each of these proteins has the same 28 C-terminal residues as profilin-II (Pollard & Rimm, 1991) . Identical results were obtained with antibody P1 (data not shown). Neither antibody binds to native profilin or any of the mutants in solution. We conclude that antibodies P1 and P2 bind epitope(s) at the extreme C terminus that are not exposed in native profilin. The epitope includes the last three residues, Q123-G124-F125 (see Figure 2) .
Antibody P8 binds to all of the C-terminal deletions of profilin-II and to the internal deletions rPIID61-65A and rPIID47-65, but it does not bind to the internal deletions rPIID16-46 and rPIID5-62 ( Figure 7B ). This shows that the epitope for antibody P8 is between residues 16 and 46 and is probably continuous, because P8 does not bind to native profilin in solution. Identical results were obtained with antibody P9 (data not shown), so it may be a sister clone of the same hybridoma cell as P8. Residues 22 to 44 are shown in yellow in Figure 2 . Both antibodies bind to rPIIW2C and rPIIW29C by ELISA (data not shown), so neither of the tryptophans (shown in blue in Figure 2 ) is necessary for their binding. 35 S]methionine labeled antibody to profilin-II was measured in the presence of 01000-fold molar excess concentration of each other antibody. For each labeled antibody, the CPM bound to profilin in the presence of 01000-fold molar excess control antibodies to actophorin or myosin-II is defined as 100% binding (row C). CPM bound to profilin in the presence of 01000-fold molar excess of unlabeled, homologous antibody is defined as 0% binding (diagonal row from top left to bottom right). CPM bound to profilin in the presence of 01000-fold molar excess of unlabeled, heterologous antibody is expressed as a percentage, relative to the controls for each labeled antibody (columns P1 to P9). both the C terminus and around S92. S92 is part of the surface loop that connects strand b7 and strand b8 adjacent to the C terminus (Figure 2 ). By ELISA, antibody P5 binds to wild-type profilin-II and the point mutants rPIIW2C and rPIIW29C equally well (data not shown).
The binding of antibody P7 is sensitive to the substitution of cysteine for S76 (shown as a red side-chain in Figure 2) but not S92 (shown in lavender in Figure 2 ). In solution ( Figure 8C ) or solid phase ELISA (data not shown), antibody P7 has an apparent K d that is five to ten times higher for rPIS76C than for wild-type profilin or rPIS92C. Therefore, S76 is in the vicinity of a determinant for the conformational epitope of antibody P7. S76 is the first hydrogen-bonded residue in strand b6 after the surface loop connecting strand b5 to strand b6 (Figure 2 ). Antibody P7 also binds wild-type profilin-II and the point mutants rPIIW2C and rPIIW29C equally well by ELISA (data not shown). The ability of P7 to bind the two substitution mutants rPII 122PLV and rPII 122PSSLD in solution ( Figure 8C ) distinguishes it from antibodies P4, P5 and P6, which do not.
Antibodies P4 and P6 bind equally well to wild-type profilin-I, profilin-II and the point mutants rPIS76C and rPIS92C in both solution and ELISA (data not shown), but neither of these antibodies binds to the point mutants containing tryptophan substitutions, rPIIW2C and rPIIW29C by ELISA (data not shown). Therefore, antibodies P4 and P6 probably bind to determinants around the two tryptophans (shown in blue in Figure 2 ) near the N terminus, in addition to determinants at the C terminus.
Competitive binding
Competition between antibodies for binding to profilin confirmed and extended our information about the localization of the epitopes. We labeled each monoclonal antibody biosynthetically and measured its binding to profilin in the presence of excess concentrations of each unlabeled antibody using solid phase binding assays. The apparent K d values of the antibodies for normal wild-type profilin (Table 2 ) are all within one order of magnitude of each other, so with 1000-fold molar excess competitors, the different affinities should not contribute to the results in a major way. Each antibody can be assigned to a competitive binding group based on the results shown in Figure 9 . For example, antibodies P1 and P2 are in one competitive binding group because P1 inhibits P2 (0%) and P2 inhibits P1 (20%). Antibodies P8 and P9 form another competitive binding group. Antibody P3 is in a group of its own. The four antibodies that bind to native profilin in solution (P4, P5, P6 and P7) also form a competitive binding group (see Figure 9 ). Some antibodies that bind to denatured epitopes inhibit the binding of antibodies to native epitopes. This interesting phenomenon is considered in the discussion along with the curious
Antibodies that bind to native epitopes
Antibodies P4, P5, P6 and P7 bind to native and recombinant profilin-I and profilin-II in solution, ELISA and immunoblots (Table 2 ) and even to the internal deletion rPIID61-65A ( Figure 7E ). However, none of these four antibodies binds to rPII 117PLV (data not shown) and only antibody P7 binds to the substitution mutants rPII 122PLV and rPII 122PSSLD ( Figure 8C ). These results suggest that the extreme C terminus is a major determinant for the epitopes of antibodies P4, P5 and P6 and to a lesser extent, antibody P7. The differential binding of these four antibodies to the point mutants rPIS76C, rPIS92C, rPIIW2C and rPIIW29C identifies additional determinants for these antibodies, which helps to distinguish their epitopes. The relation of these residues to each other and the C terminus is shown in Figure 2 .
The binding of antibody P5 is sensitive to the substitution of cysteine for serine at position 92 (shown in lavender in Figure 2 ), but not at position 76 (shown as a red side-chain in Figure 2 ). Using either solution binding ( Figure 8B ) or ELISA (not shown), antibody P5 has an apparent K d that is five to ten times higher for rPIS92C than for wild-type profilin or rPIS76C. Therefore, the conformational epitope for antibody P5 consists of determinants at enhancement of antibody P3 binding (229%) by antibody P1.
Note the weak but consistent inhibition of antibodies P1 (46%) and P2 (47%) on the binding of antibody P8. Similar effects are observed on the binding of antibody P9 (Figure 9 ). Even at molar ratios of 1000:1 we could not reduce the binding below approximately 50%. This result suggests the possible existence of two or more profilin conformations, only half of which are able to bind both antibodies (e.g. P1 and P8).
The profilin-II specific antibody P9 inhibits antibody P7 (0%) but has little effect on the binding of antibodies P4 (89%) and P5 (90%). These observations corroborate the result that P7 binds the substitution mutants rPII 122PLV and rPII 122PSSLD ( Figure 8B and C) , whereas P4 and P5 do not (data not shown).
Effects of the monoclonal antibodies on profilin-actin interactions
We used the solid phase assays to test the effect of actin on antibody binding. We compared the binding of antibodies to profilin and profilin-actin complexes using both ELISA ( Figure 10A ) and immunoblotting ( Figure 10B ). Additionally, we tested different mixtures of antibodies and profilin for their effects on actin polymerization in solution ( Figure 10C ).
By ELISA, antibody P1 binds equally well to profilin-II adsorbed to microtiter wells in the presence or absence of actin ( Figure 10A ). Similar results were obtained with antibodies P2, P8 and P9 (data not shown). However, the reaction of antibodies P4 and P7 ( Figure 10A ) and antibodies P3, P5 and P6 (not shown) is much weaker in the presence of actin than in its absence. By immunoblotting, antibodies P1, P2, P4 and P6 all bind profilin-I that is covalently crosslinked to actin, but antibodies P3, P5 and P7 do not ( Figure 10B ). All of the antibodies bind to uncrosslinked profilin-I except for the profilin-II specific antibodies P8 and P9 ( Figure 10B ). When tested against crosslinked complexes of profilin-II with actin, antibody P8 binds like P1 and antibody P9 binds like P4 in Figure 10B (data not shown).
Mixtures of antibody P4 and profilin inhibit the spontaneous polymerization of actin more strongly than profilin alone, while antibodies P5 and P7 block the inhibition of spontaneous actin polymerization by profilin ( Figure 10C ). Antibody P1 ( Figure  10C ) and antibodies P2, P3, P8 and P9 (data not shown) have little if any effect in this assay, since they do not bind to wild-type profilin in solution. However, antibody P3 binds to the deletion mutant rPII 117PLV in solution ( Figure 8A ) and blocks the inhibition of spontaneous actin polymerization by this mutant (data not shown; see Figure 6 ). Antibodies P4 ( Figure 10A ) and P6 (data not shown) do not bind to mixtures of profilin and actin by ELISA. This differs from the immunoblot results ( Figure 10B ) and the polymerization results ( Figure 10C ), most likely due to conditions on the surface of the microtiter plate.
Effects of the monoclonal antibodies on profilin binding to poly-L-proline
Only the antibodies that bind to wild-type profilin in solution (P4, P5, P6 and P7) inhibit the binding of iodinated mixtures of profilin-I and profilin-II to poly-L-proline using the pelleting assay with poly-L-proline beads (Figure 11 ). Similar results were obtained when profilin-I and profilin-II were tested separately (data not shown).
Discussion
Localization of epitopes for the monoclonal antibodies
We localized the epitopes for our collection of monoclonal antibodies using various deletion and substitution mutants as well as competitive binding experiments. These two approaches produced complementary and generally consistent evidence regarding the locations of the antibody binding sites, which are summarized in Figure 2 and Table 2 .
Antibodies P1 and P2 bind to an epitope including the last three residues at the C terminus of the polypeptide chain and an unknown number of adjacent residues. These antibodies do not bind to native profilin in solution, but do bind to profilin molecules known or suspected to be denatured due to internal deletions or to immobilization on plastic or nitrocellulose, so the epitope is buried in the native protein. P1 and P2 have the same isotype and compete for binding profilin, but they are not the same antibody, since they differ in the way that they interact with other antibodies. For example, P1 enhances the binding of P3, while P2 mildly inhibits the binding of P3. P1 and P2 both compete with the group of antibodies with determinants near the C terminus (P4, P5, P6 and P7) and with the two profilin-II specific antibodies (P8 and P9) that bind to the turns and helix underlying the C terminus. Perhaps due to the peculiar nature of the denatured epitope for P1 and P2, none of these other antibodies competes with either P1 or P2.
The epitope for antibody P3 includes residues between 101 and 104 that form the loop connecting strand b8 to helix a4 in the native protein (shown in orange in Figure 2 ), but the binding site is not exposed unless the protein is destabilized by internal or C-terminal deletions or immobilization on plastic or nitrocellulose. Since P3 binds recombinant profilin lacking the trimethylated Lys103 present in the ameba profilin (Ampe et al., 1988) , this modification is not essential for the interaction. The binding of antibody P3 is largely unaffected by other antibodies except for the enhancement caused by antibody P1, which binds to the opposite end of the 2.7 nm long C-terminal helix a4. This distance is very similar to the Figure 10 . Effects of monoclonal antibodies on the interaction of profilin with actin. Binding of antibodies to mixtures of actin and profilin by ELISA. Samples of 2 mM wild-type profilin-II were incubated in the absence (open symbols) or the presence (filled symbols) of 10 mM rabbit actin in buffer A and adsorbed to microtiter wells. The binding of different antibody dilutions to each sample was measured by ELISA. Circles, antibody P1; triangles, antibody P4; squares, antibody P7. B, Binding of antibodies to crosslinked complexes of actin and profilin by immunoblotting. Profilin-I and Acanthamoeba actin were chemically crosslinked with EDC, run on a 15% (w/v) SDS-PAGE gel and transferred to nitrocellulose paper. Individual strips were incubated with monclonal antibodies followed by 125 I-labeled goat anti-mouse second antibodies. The Figure is an autoradiogram. AP, actin-profilin-I crosslinked complex; P, uncrosslinked profilin I. The antibody names are indicated at the top of each strip. No first antibody was added to the strip labeled Control. The anti-actin monoclonal antibody (4D6 IgG1, a gift from Dr James Lessard) bound to both actin and the crosslinked profilin-I-actin complex. (data not shown). C, Binding of antibodies to profilin-II measured by effects on actin polymerization. The bold-faced curves show the spontaneous, salt-induced polymerization of 10 mM Acanthamoeba actin monitored by light scattering without profilin-II (upper curve) and with 6 mM profilin-II (lower curve). The thin curves show the effects on actin polymerization of samples of 6 mM profilin-II pre-incubated with 12 mM antibodies. The curves are labeled for each antibody (P1, P4, P5 and P7). The effect of antibody P4 on actin polymerization without profilin-II is shown in the curve labeled P4c. None of the other antibodies had any effect on actin polymerization in the absence of profilin (data not shown).
inter-epitope distances required for the cooperative binding of monoclonal antibodies to the tail of myosin-II, another a-helical structure (Rimm et al., 1990) .
Antibodies P8 and P9 compete with each other and bind to similar or identical denatured epitopes between residues 16 and 46. Since these antibodies are specific for profilin-II, a sequence comparison with profilin-I provides additional clues about the position of their epitopes. The differences are (PI no. PII): L22I, L24H, T38S, Q41N, Q43A and T44A. Therefore, antibodies P8 and P9 probably bind to a continuous epitope between residues 22 and 44 (shown in yellow in Figure 2 ) that is not exposed in the native protein. We favor the region around L24H, since this is one of the main charge differences responsible for the higher isoelectric point of profilin-II relative to profilin-I (Ampe et al., Figure 11 . Effects of the monoclonal antibodies on the binding of profilin to poly-L-proline. A 10 mg sample of each monoclonal antibody was incubated at room temperature for one hour with 0.3 mg (050,000 CPMs) of iodinated profilin-I and profilin-II in 0.4 ml of PBS containing 20% FBS. A 20 ml sample of packed poly-L-proline beads were added for 15 minutes and pelleted in a microfuge. Samples of the supernatants were counted in a gamma counter to determine the amount of free and bound profilin. The Figure shows the amount of radioactivity in the pellet for each monoclonal antibody (P1 to P9). A1 is a monoclonal antibody to Acanthamoeba actophorin that does not bind to profilin, and C shows the amount of radioactive profilin pelleting with poly-L-proline without antibody added.
are on the opposite side of the C-terminal helix a4 from those of P5 and P7 ( Figure 2) . As described below, the effects of actin on the binding of these antibodies to profilin and the effects of these antibodies on profilin binding to actin are entirely consistent with our conclusions about the location of the antibody binding sites (Figure 2) .
Location of the actin binding site on profilin
The monoclonal antibodies beautifully frame the actin binding site on profilin (shown in blue and green in Figure 2 , bottom), providing independent evidence that confirms previous conclusions from X-ray crystallography and chemical crosslinking (Vandekerckhove et al., 1989) . Crosslinking showed that Lys115 (shown in green in Figure 2 ) in both Acanthamoeba profilin-I and profilin-II contacts Glu364 of actin (Vandekerckhove et al., 1989) . In the crystallized complex of b-actin with bovine profilin , actin contacts profilin residues from the proximal half of the C-terminal helix a4, the exposed b-sheet consisting of strands b5, b6 and b7 and helix a3 (shown in blue and green in Figure 2 , bottom). The effects of antibodies P5 and P7 confirm that the left-hand side of the actin binding site is at the edge of the exposed b-sheet underlying the C terminus (Figure 2 ). Antibodies P5 and P7, which bind to the C terminus of helix a4 and residues on the adjacent b-sheet, inhibit profilin binding to actin and do not bind to crosslinked complexes of profilin and actin. On the other hand, antibodies P4 and P6, which bind to the C terminus of helix a4 and determinants near W2 and W29 (shown in blue in Figure 2 , top), do bind to crosslinked complexes of profilin and actin. Also, antibody P4 does not block profilin binding to actin, but seems to enhance its effect on actin polymerization. Furthermore, the rPII 117PLV mutant shows that the last eight C-terminal residues are not required for actin binding.
Antibody P3 defines the other side of the actin binding site, the b8/a4 loop (shown in orange in Figure 2 ). Although P3 does not bind to wild-type profilin in solution, it binds its denatured epitope in the unstable deletion mutant rPII 117PLV in solution. This surprising property allowed us to show that P3 interferes with actin binding by this mutant in the actin polymerization assay. This effect and the inability of P3 to bind to either mixtures of profilin and actin in ELISA or chemically crosslinked complexes of profilin and actin on immunoblots shows that the actin binding site extends to near the proximal end of helix a4.
Our results confirm that the proximal half of helix a4 and the adjacent b-sheet is a major contact between profilin and actin in solution, as shown most clearly in the X-ray structure of the cocrystal of bovine profilin and b-actin . Curiously, the primary structure of part of this binding site is found in Acanthamoeba myosin-II. The region spanning residues 75 to 89 of both Acanthamoeba profilin-I and profilin-II, consisting 1988; and Table 1 ). This puts the epitope near the loop connecting strands b1 and b2 in the native profilin structure.
Antibodies P4, P5, P6 and P7 compete with each other for binding to native profilin. Minor substitutions or deletions at the C terminus abrogate the binding of P4, P5 and P6, without affecting actin binding, so we conclude that the C-terminal residues participate directly in binding these antibodies. P7 competes with P4, P5 and P6, but binds to mutants with substitutions of the last three residues. Thus, the P7 epitope overlaps but is distinct. Point mutations further distinguish among these antibodies. Antibody P5 alone is sensitive to the substitution of cysteine for S92 (shown in lavender in Figure 2 ), so it binds to the C terminus and the adjacent b7/b8 loop. Antibody P7 alone is sensitive to substitution of cysteine for S76 (shown in red in Figure 2) , which is largely buried in the native protein. Consequently, the cysteine substitution probably alters the arrangement of overlying residues. The b5/b6 loop adjacent to S76 is the most hydrophilic part of the profilin sequence by the criteria of Hopp & Woods (1983) and the corresponding residues in human profilin have high mobilities , so it is a potential determinant for P7. Unlike P5 and P7, antibodies P4 and P6 are sensitive to the substitutions W2C and W29C (shown in blue in Figure 2 ) near the N terminus, so their determinants primarily of strand b6, a loop and strand b7 (shown in red in Figure 2 ), is 53% identical to residues 630 to 644 of myosin-II (Hammer et al., 1987) . The sequence similarity to myosin-II from other species is less remarkable. The corresponding residues of Dictyostelium myosin-II (Schroder et al., 1993) and muscle myosin (Rayment et al., 1993a,b) participate in actin binding, but are disordered in the crystal structure of subfragment-1 (Rayment et al., 1993a,b) . This b-strand-loop-b-strand segment of profilin (75 to 89) is also similar in sequence and secondary structure to actin residues 236 to 250 (20% identical; Kabsch et al, 1990) and pleckstrin residues 7 to 22 (31% identical; Yoon et al., 1994) . Pro243 in the actin loop appears to make a direct contact with an adjacent actin monomer in the F-actin model of Lorenz et al. (1993) . Several of these pleckstrin residues may be part of a PIP2 binding site (Harlan et al., 1995) as proposed for the homologous segment of profilin (Sohn et al., 1995; Federov et al., 1994) . These homologous structures, comprising possible PIP2 and actin binding sites of profilin, provide a structural explanation for the competition of these two ligands (Lassing & Lindberg, 1985) .
Localization of the poly-L-proline binding site on profilin
Our new observations confirm that the extreme C terminus of profilin is essential for binding poly-L-proline, as suggested by mutational analysis, phylogenetic comparisons and demonstrated most directly by NMR. Poly-L-proline causes large changes in the chemical shifts of atoms in residues clustered in the groove (Figure 2 ) between the N-terminal (a1) and C-terminal (a4) helices of both Acanthamoeba profilin (Archer et al., 1994) and human profilin (Metzler et al., 1994) . These residues are among the most conserved in profilin (Cedergren-Zeppezauer et al., 1994; Bjorkegren et al., 1993) , a family of proteins otherwise noted for the great variability of their primary structures (Pollard & Quirk, 1994) . All of these highly conserved hydrophobic (and largely aromatic) residues (W2, Y5, W29, Y119, L120 and F125) interact directly with poly-L-proline. Vaccinia profilin, the only known naturally occurring profilin that does not bind poly-L-proline, has non-conservative substitutions in some of these residues, including those corresponding to ameba profilin Y5, W29 and Y119 (Machesky et al., 1994a,b) . Likewise, experimental point mutants of human profilin, W3N and H133S (Bjorkegren et al., 1993;  corresponding to ameba profilin W2 and Y119), or ameba profilin-II (W2C or W29C; Vinson & Pollard, unpublished results) do not bind well to poly-L-proline. Deletion of the last three residues of yeast profilin nearly eliminated binding to poly-L-proline (Haarer et al., 1993) .
Deletion and substitution of as few as three residues at the C terminus of ameba profilin, including F125, reduced the affinity of profilin for poly-L-proline by at least 100-fold. Deletion of the last eight residues, including Y119, I120 and F125, completely abolished poly-L-proline binding. This loss of poly-L-proline binding is attributable to the loss of these residues, rather than due to the known effect of these mutations on the stability of the protein, since these mutants have native conformation at room temperature and still bind to actin. Additionally, the substitution mutants rPII 122PLV and rPII 122PSSLD still bind to monoclonal antibody P7.
The effects of the monoclonal antibodies further confirm the location of the poly-L-proline binding site on profilin. Antibodies P4, P5, P6 and P7, with epitopes at or near the C terminus, all inhibit the binding of profilin to poly-L-proline. Since none of our antibodies bind profilin and poly-L-proline simultaneously, we cannot control the unlikely possibility that any antibody binding to native profilin interferes with poly-L-proline binding. Thus, these results are consistent with, but not as strong as the other evidence for the location of the poly-L-proline binding site.
Effect of C-terminal substitutions and deletions on the structure of profilin
Relatively minor deletion and substitution mutations at the C terminus destabilize profilin. Minimal changes lower the concentration of urea or the temperature required to denature the mutant protein or to promote ANS binding. C-terminal deletion and substitution mutations cause proportional changes in the DG°for unfolding in urea and in the activation enthalpy (DH ‡) for ANS binding, indicating that these properties are sensitive to the same underlying alteration in the mutant proteins. In spite of this instability, these mutants have normal secondary structure and bind to actin. Deletion of eight residues creates a remarkable protein, rPII 117PLV, that is stable enough to purify from E. coli and binds to actin, but has many properties characteristic of the equilibrium molten globule state, a proposed intermediate in protein folding (Ptitsyn, 1992; Kuwajima, 1989; Christensen & Pain, 1991) . Like a molten globule, rPII 117PLV has wild-type secondary structure, but has a slightly expanded hydrodynamic radius, decreased stability to denaturation and binds ANS (Semisotnov et al., 1991) . The ability of this mutant to bind monoclonal antibody P3 confirms that it is partially unfolded. Denaturants or extremes in pH can promote the molten globule state, but a C-terminal deletion of Staphylococcus nuclease results in a similar compact structure that, however, lacks much of the secondary structure characteristic of molten globules and our mutants (Flanagan et al., 1992) . Molten globules contain much native secondary structure, but lack the packing of these secondary structure elements necessary for a stable, compact, tertiary structure (Peng & Kim, 1994) .
Dependence of antibody binding on the structure of profilin
The ability of monoclonal antibodies that bind to native profilin in solution (P4, P5, P6 and P7) to also bind to profilin on immunoblots and ELISA suggests that some profilin renatures under these conditions. The inability of these antibodies to bind most of the deletion and substitution mutants in these assays suggests that they are incapable of renaturation. Only the least severe internal deletion, rPIID61-65A, can refold into a structure that binds these antibodies weakly. On the other hand, some profilin is denatured on immunoblots and ELISA, because the antibodies that do not bind profilin in solution (P1, P2, P3, P8 and P9) bind to profilin in these assays.
These observations could be explained by a mixture of native and denatured profilin molecules, but we have several clear examples where antibodies to denatured epitopes inhibit the binding of antibodies to native epitopes in the ELISA. Antibody P1 (denatured epitope) inhibits four antibodies that bind to native epitopes: P4 (2%), P5 (0%), P6 (27%) and P7 (0%; see Figure 9 ). Also, antibody P8 (denatured epitope) inhibits antibodies P6 (11%) and P7 (0%; Figure 9) .
How is this possible? One mechanism is that many of the profilin molecules immobilized on plastic in the solid phase ELISA were partially folded into native structures. If the native and denatured epitopes were on two distinct populations of profilin, the antibodies to the native and denatured epitopes would not compete. Another possibility is that when profilin adsorbs to plastic, antibodies to denatured epitopes bind and prevent the folding of the native structures required for the binding of antibodies to native epitopes. Since we do not observe inhibition of antibodies to denatured epitopes by antibodies to native epitopes, we favor the latter suggestion.
Interpretation of mutant phenotypes and the role of profilin ligands in profilin physiology
Our new results may help interpret the phenotypes of yeast cells expressing similar mutant profilins (Haarer et al., 1993) . Yeast and ameba profilins lacking three to four residues from the C terminus bind very poorly to poly-L-proline, but expression of these yeast deletion mutants rescues S. cerevisiae with null mutations in the wild-type profilin gene (Haarer et al., 1993) . This suggests that the binding of profilin to cytoplasmic proteins like VASP, mediated by proline-rich sequences (Reinhard et al., 1995) , may not be essential for profilin function in yeast. On the other hand, yeast profilin mutants lacking six to eight residues from the C terminus do not rescue profilin null mutants, in spite of the fact that these mutants can bind actin (Haarer et al., 1993) . This suggests that actin binding is not sufficient for normal profilin function. However, while binding of yeast D6-8 mutants to DNase I-actin affinity columns was determined at 4°C, the profilin null cell rescue experiments were conducted at 22°C. Our characterization of rPII 117PLV clearly shows that, despite its ability to bind to actin at 20°C, this molten globule-like protein is on the verge of unfolding at this temperature. The intrinsic fluorescence and extremely low free energy of denaturation of this mutant (1.8 kcal/mole) at 20°C and its binding to ANS and increased Stokes' radius at 5°C exemplify this. In fact, the mutants rPII 117L and rPII 115PLV were completely unstable (insoluble) even at 4°C. We conclude that the inability of the D6-8 mutants to rescue profilin null yeast cells is a consequence of their thermodynamic instability, as suggested by Haarer et al. (1993) . Therefore, yeast cell viability depends on the expression of profilin that binds to actin.
Materials and Methods
Cloning and expression of recombinant profilin
Full-length cDNAs for Acanthamoeba profilin-I and profilin-II (Pollard & Rimm, 1991) were modified by polymerase chain reaction (PCR) and cloned into the NdeI and StuI sites of the vector pMW172. The sequences were confirmed and the final expression constructs transformed into BL21 (DE3) E. coli cells (Way et al., 1990) . Expression from the profilin ATG start codon is under control of the promoter for the bacteriophage T7 RNA polymerase inducible by isopropyl-b-D-thiogalactopyranoside (IPTG). Cells were grown at 37°C on a rotary shaker in two liter Erlenmeyer flasks containing 500 ml of LB broth supplemented with 100 mg/ml ampicillin. IPTG was added to 0.5 mM when the cultures reached an absorbance of 1.0 at 600 nm and the incubation was continued overnight. Typically, 50 to 100 mg of profilin were obtained from one liter of culture medium.
C-terminal deletion mutagenesis of recombinant profilin-II
Plasmid MW172 containing the coding region for profilin-II was linearized with EcoRI and digested with Bal31 nuclease. After releasing deleted fragments from the vector with NdeI, the fragments were gel purified and their 3' ends were blunted using the Klenow fragment of DNA polymerase. These fragments were then recloned into pMW172 between the NdeI and StuI sites and transformed into DH5a E. coli cells. XbaI released inserts were screened by agarose gel electrophoresis and clones of various sizes were sequenced to identify the deletions. Selected deletion mutant plasmids were then transformed into BL21 (DE3) E. coli cells for expression. Each deletion mutant acquired between one and five additional residues at its C terminus, depending on the phase of the vector stop codons. Mutants were named by the residue number of the last wild-type profilin residue followed by any additional residues indicated by single letter code (see Figure 1 , Table 1 and Results).
Internal deletions and site-directed mutagenesis
Plasmid MW172 containing the coding region for profilin-II was digested with two unique restriction enzymes within the coding region and the ends were treated with either mung bean nuclease or the Klenow fragment of DNA polymerase to generate compatible blunt ends in the correct reading frame. After reclosing the vector with DNA ligase and transforming DH5a E. coli cells, deletions were confirmed by restriction digests and DNA sequencing. Appropriate plasmids were then used to transform BL21 (DE3) E. coli cells for expression. The four internal deletions were named by the residues that were deleted. The names of the internal deletions with the restriction sites used to create them shown in parentheses are: rPIID5-62 (BsiwI/SacI), rPIID16-46 (NarI/BalI), rPIID47-65 (BalI/MluI) and rPIID61-65A (SacI/MluI). This last construct was obtained only when the DNA was cut first with SacI and then MluI. An additional alanine residue (denoted in the name) was acquired as a result of the construction of this mutant. Serine residues 76 and 92 of profilin-I and tryptophan residues 2 and 29 of profilin-II (Vinson & Pollard, unpublished results) were converted to cysteine by site-directed mutagenesis.
Protein purification
Acanthamoeba profilin was purified by chromatography of extracts on DEAE-cellulose followed by either conventional chromatography (Kaiser et al., 1986) or poly-L-proline agarose affinity chromatography . The two isoforms, profilin-I and profilin-II, were separated by cation exchange chromatography on CM-CM-cellulose (Kaiser et al., 1986 . Recombinant profilins were extracted from E. coli by sonication (40% duty cycle, setting of 4 to 6) for four minutes on ice using a Branson 450 sonifier (Branson Ultrasonics Corp., Danbury, CT) in 50 mM Tris-HCl (pH 7.8) containing 6 to 8 M urea. After centrifugation at 40,000 g for 20 minutes at 4°C, profilin was purified from supernatants on DEAE and poly-L-proline/agarose . Mutant profilins that did not bind to poly-L-proline were purified by chromatography of extracts on DEAE and by gel filtration on S-300 in 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 100 mM glycine and 1 mM dithiothreitol. Actin was purified from Acanthamoeba (Pollard, 1984) and rabbit skeletal muscle (MacLean-Fletcher & Pollard, 1980) .
Monoclonal antibodies
Mouse monoclonal antibodies to profilin-I and profilin-II were produced and characterized using the methods of Kiehart et al. (1984) . Briefly, Balb/C mice were immunized (intraperitoneally) with 50 to 100 mg of normal Acanthamoeba profilin-I and/or profilin-II in 0.5 ml of a 1:1 mixture of protein in Dulbecco's phosphate buffered saline and Freund's complete adjuvant (GIBCO, Grand Island, NY). Subsequent immunizations were made at two-week intervals using Freund's incomplete adjuvant (GIBCO). Final immunizations (intraperitoneally and subcutaneously) were made every day for four days prior to cell fusions in Dulbecco's PBS with or without Freund's incomplete adjuvant. A number of 10:1 mixtures of spleen cells from immunized mice and P3/X63/Ag8.653 myeloma cells were fused in polyethyleneglycol, Mr 4000 (Merck, Darmstadt, Germany) and seeded into 96-well plates (NUNC, Denmark) at 250,000 cells/well in hypoxanthine/ aminopterin/thymidine (HAT) medium [(Dulbecco's modified Eagle's medium (DMEM)-HG; GIBCO) supplemented with 10% (w/v) National Cancer Tissue Culture medium (GIBCO) and 20% (v/v) fetal bovine serum (HY-CLONE Laboratories, Logan, UT)]. Cells secreting anti-profilin antibodies were screened by ELISA and cloned into soft agar (Difco Laboratories, Detroit, MI). Positive clones were grown as ascites tumors in Balb/C mice for production of monoclonal antibodies. Antibodies from ascites fluid were purified by ammonium sulfate fractionation and DEAE-cellulose chromatography as described (Kiehart et al., 1984) . A mouse monoclonal antibody to actin (4D6, IgG) was kindly provided by Dr James Lessard (1988) .
Biochemical methods
Actin polymerization
The time course of the spontaneous, salt-induced polymerization of actin was monitored by 90°light scattering at 400 nm in a Perkin-Elmer 640S fluorescence spectrophotometer. All experiments were done using gel-filtered Acanthamoeba or rabbit actin monomers in Buffer G (8 mM Tris-HCl (pH 7.5), 0.1 mM CaCl2, 0.5 mM dithiothreitol and 0.2 mM ATP). Wild-type and mutant profilins were dialyzed into Buffer G and added in varying concentrations to 5 to 10 mM actin at room temperature. Polymerization was induced by adding one tenth volume of concentrated salts to give final concentrations of 50 mM KCl, 1 mM MgCl2, 1 mM EGTA and 10 mM Tris-HCl (pH 7.5). For antibody inhibition experiments, 1.2 ml of purified monoclonal antibodies at 5 to 30 mM were dialyzed against Buffer G and clarified in a microfuge for five minutes. A 1 ml quantity of clarified antibody was transferred to a plastic fluorimeter cuvette and profilin in Buffer G was added to 6 mM. The samples were degassed for one hour at room temperature and actin monomers in Buffer G were added to a final concentration of 6 to 12 mM prior to polymerization. Monoclonal antibodies to actophorin (Quirk et al., 1993) or myosin-II (Kiehart et al., 1984) were used as controls.
Enzyme-linked-immunoadsorbant assay (ELISA)
Samples of 1 mg of purified native, recombinant or mutant profilins or complexes of profilin with actin and/or poly-L-proline (14,000 Mr) were adsorbed to Immulon-II microtiter wells (Dynatech Laboratories, Alexandria, VA) in 50 ml of 10 mM Tris-HCl (pH 7.8). Unadsorbed protein was aspirated off and the wells were washed four times with buffer (10 mM Tris-HCl (pH 7.8), 100 mM NaCl, 0.1% (v/v) Tween-20 and 0.005% (w/v) Thimerosal). After blocking unadsorbed sites with buffer containing either 2% (w/v) bovine serum albumin or 2% (v/v) fetal bovine serum (ELISA buffer), antibody dilutions (100 ml) in ELISA buffer were added to the wells and incubated for one hour at room temperature. For some experiments using actin-profilin complexes, the detergent was omitted and the salt concentration was reduced to 50 mM. The ELISA wells were processed as previously described with horseradish peroxidaselabeled second antibodies and the chromogenic substrate ortho-phenylenediamine .
Competitive binding assays
Monoclonal antibodies were labeled biosynthetically by growing 10 6 to 10 7 hybridoma cells overnight in 3 ml of methionine-free Roswell Park Memorial Institute medium (GIBCO) supplemented with 50 mCi of [
35 S]methionine (1200 Ci/mM, 10 mCi/ml; New England Nuclear, Boston, MA). After centrifugation to remove cells, unincorporated label was removed by dialysis. Labeled antibody concentrations were determined by comparing their titers with those of purified antibodies of known concentration by ELISA. Specific activities between 10 5 and 10 6 CPM/mg IgG were obtained using this method. For solid phase competitive binding assays, 100 ml of ELISA buffer containing 10 to 100 ng (10 4 CPM) of radioactive antibody and 100 mg of unlabeled (cold) antibody was incubated for two hours or overnight in microtiter wells with profilin-I or profilin-II adsorbed, as for ELISA. For more quantitative experiments, nanomolar concentrations of radioactive antibodies were incubated in the presence of various concentrations (10 −13 to 10 −5 M) of cold, competing antibodies for binding to profilin adsorbed to microtiter wells. Incubations and rinses were done as described for ELISA. Bound antibody was quantified by adding the rinsed and dried microtiter wells to 5 ml of Ecolume scintillation cocktail (ICN Biochemicals, Irving, CA) and counting in a Beckman LS-7000 scintillation counter.
For solution binding, unlabeled antibodies at concentrations near their apparent Kd values (10 −7 to 10 −8 M) were incubated in 100 to 200 ml of ELISA buffer in microtiter wells containing various concentrations of purified wild-type or mutant profilins (10 −14 to 10 −4 M). After incubation for two hours at room temperature or overnight at 4°C, 25 to 50 ml aliquots were transferred to microtiter wells containing adsorbed profilin and processed by ELISA.
Chemical crosslinking
Profilins were crosslinked to actin monomers with a water-soluble carbodiimide as described by Vandekerckhove et al. (1989) . After stopping the reactions, samples were boiled for two minutes in SDS sample buffer and electrophoresed on 12% to 15% (w/v) polyacrylamide gels (Laemmli, 1970) . Immunoblotting was carried out as described by Kiehart et al. (1983) .
Isoelectric focusing
Non-equilibrium isoelectric focusing of profilins (20 mg/lane) was carried out at 5°C using 0.5 mm thick agarose slab gels containing 2% (w/v) Pharmolyte ampholines (pH 3 to 10; Sigma Chemical Co., St Louis, MO) cast on Gel-bond film (Marine Colloids Div., FMC Corp., Springfield, NJ). Gels were run at 5 to 10 W constant power on an LKB Multiphor II electrophoresis unit (LKB Instruments Inc., Gaithersburg, MD) until current reached a minimum value (3 to 9 mA).
Poly-L-proline pelleting assay
Profilin was radio-labeled with 125 I (Amersham, Arlington Heights, IL) using IODOBEADS as described by the manufacturer (Pierce, Rockford, IL). Samples of unlabeled or iodinated profilin were incubated at 25°C first for one hour with molar excess concentrations of monoclonal antibodies in 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 100 mM glycine, 1 mM dithiothreitol and 10% (v/v) fetal bovine serum and then for 15 minutes with 20 ml of packed Sepharose-4B beads (Pharmacia, Uppsala, Sweden) coupled according to Kaiser et al. (1989) with poly-L-proline, Mr 14,000 or 30,000 (Sigma Chemical Co., St Louis, MO). Profilin in the supernatants and the pellets was quantified by SDS-PAGE for unlabeled profilin or by gamma counting in a Beckman Gamma 4000 counter for iodinated profilin.
Fluorescence spectroscopy
The intrinsic fluorescence of profilin and profilin mutants was measured with a Perkin-Elmer 650-10S fluorescence spectrophotometer. The temperature of the sample was controlled by circulating water through a custom jacketed cuvette holder. Poly-L-proline binding was measured by changes in intrinsic fluorescence (Metzler et al., 1994; Perelroizen et al., 1994; Machesky, 1993 ) using excitation at 295 nm and emission at 325 nm. Titrations were done by adding samples of concentrated poly-L-proline (10 mg/ml, 6 or 30 kDa) with 4 mM profilin to a 2 ml sample of 4 mM profilin.
Equilibrium denaturation experiments
The unfolding of profilins and profilin mutants in urea was monitored spectrofluorometrically at 350 nm with excitation at 295 nm. Apparent equilibrium association constants (Kapp) were calculated by difference spectroscopy from the best least squares linear fits of native and denatured baselines, assuming a single transition between the folded (F) and unfolded (U) states. The free energy of unfolding (DG°F-U) was determined by extrapolating to zero urea the best least squares linear fit of − RT ln Kapp versus urea concentration (Santoro & Bolen, 1988) .
Circular dichroism spectroscopy
CD spectra were taken in a 0.1 mm path length cuvette with a AVIV model 60DS Spectropolarimeter (AVIV Associates, Lakewood, NJ) at 21°C at 0.5 nm per second. Four scans of each sample were averaged and corrected for the buffer signal. The spectra were analyzed using the PROSEC software with the calibration data of Chang et al. (1978) .
ANS binding
ANS from Molecular Probes, Inc. (Eugene, OR) was dissolved at a concentration of 10 to 20 mM in 10 mM Tris-HCl (pH 7.8) and the concentration was confirmed by absorption using an extinction coefficient of 7930 M −1 cm −1 . Interaction with protein was evaluated by adding ANS to protein solutions and measuring the fluorescence emission at 470 nm with excitation at 390 nm. For each mutant, the enthalpy of activation, DH ‡, was calculated from the slope (m = − DH ‡/R) of the best linear least squares fit of ln(kh/kBT ) versus 1/T, where k is the initial rate of ANS binding, h is Planck's constant, kB is Boltzmann's constant, T is the absolute temperature (K) and R is the gas constant.
Analytical gel filtration
The partition coefficients of profilin and profilin mutants were measured by gel filtration on a 90 cm column of Sephadex G-100 in bead buffer at 4°C. The Stokes' radius was calculated using the method of Siegel & Monty (1966) with bovine serum albumin, carbonic anhydrase, myoglobin and cytochrome c as standards.
